Nuvation Bio Inc. Class A Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.16 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 26.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Vivmark Residential Common Shares of Beneficial Interest for 1 Days on average.
| NUVB | VMRK | |
|---|---|---|
Market Cap | $1.74B | $46.41B |
Volume | 9,289,619 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $9.54 | $70.15 |
52-Week Low | $3.41 | $57.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $55.52B |
Dividend Yield | — | 4.68% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →